India mein diabetes ki dawa ab aur bhi saasthi!
Mankind Pharma ne ek bada kaam kiya hai! Unhone Empagliflozin naam ki diabetes ki dawa ka generic version launch kar diya hai. Isse aapko yeh dawa pehle se bhi kam daam mein milegi. Aap isse Empaglyde, Empagreat, ya Dynaduo naam se pa sakte hain.
Kitne paise mein milegi yeh dawa?
10 mg wali tablet sirf Rs 5.49 mein aur 25 mg wali Rs 9.90 mein. Yeh sunke kitna accha laga, hai na? Mankind Pharma ke Vice Chairman aur Managing Director, Rajeev Juneja ne bataya ki unka target hai sabhi ko yeh dawa easily aur affordable price mein provide karana.
Kaise hua yeh sab possible?
Boehringer Ingelheim ki Empagliflozin dawa ka patent India mein expire ho gaya tha. Isliye ab kai companies iska generic version bana rahi hain. Mankind Pharma bhi inmein se ek hai. Juneja ne yeh bhi bataya ki unhone apni team ko do hisson mein baant kar yeh dawa market mein launch ki hai. Isse zyada logon tak yeh dawa pahunch payegi. Unke distribution network ki wajah se yeh dawa urban aur rural dono areas mein easily available hogi.
Aur kya khaas baat hai?
Yeh dawa international quality ki hai, aur price bhi bahut kam hai. Yeh ek bada achievement hai! Isse India mein diabetes se ladne mein bahut madad milegi. Reports ke mutaabik, kai aur companies bhi apni generic Empagliflozin dawa market mein laane wali hain. Toh ab diabetes patients ko zyada tension lene ki zaroorat nahin hai! Daawa easily aur saaste mein mil jayegi.
Mankind Pharma ki aur bhi news
Ek aur khaas baat! Mankind Pharma ne apni Mahananda Spa And Resorts mein jo stake tha woh pura beech diya hai Chalet Hotels ko. Yeh bhi business ki ek badi news hai!
Aage kya hoga?
Ab dekhna hai ki market mein is generic dawa ka kya impact hota hai. Kya yeh dawa sabhi ke liye easily available ho payegi? Yeh aane wala waqt hi batayega. Par phir bhi yeh ek achchi shuruaat hai!
